Contingency management (CM), long known to be efficacious in the treatment of substance-dependent men and women, has also been found to be efficacious for substance-dependent pregnant women. However, the specific CM reinforcement parameters in the special population of opioid-dependent pregnant women have been less fully and systematically studied. The Drug Abuse Incentive Systems (DAISY) study, a randomized controlled trial (RCT) of opioid-dependent pregnant patients, found that escalating reinforcement was not superior to a fixed reinforcement CM schedule after a 13-week intervention. To further examine CM's reinforcement parameters in this population, this study aims to test the hypothesis that there is an early treatment response showing an escalating reinforcement schedule to be significantly more efficacious than a fixed schedule after 5 weeks of intervention in opioid-dependent pregnant patients.
(Addict Disord Their Treatment 2012;11:150-153) C ontingency management (CM), awarding vouchers for achieving a targeted behavior, is efficacious for improving adherence to substance use treatment in general populations of men and women, 1 including substance-dependent pregnant women. 2 CM often results in an immediate cessation of drug use; in a meta-analysis of CM reinforcement therapy for substance use disorders, 3 studies with durations of r2 weeks and 4 studies with durations of 3 to 11 weeks had mean weighted effect sizes of 0.38 and 0.40, respectively. 3 Therefore, CM of short duration may be especially useful to use with pregnant women, who have a relatively short and defined time to respond to treatment, in order to quickly reduce fetal drug exposure and optimize the goal of both the mother and neonate being drug-free at delivery.
Cocaine and/or heroin use during pregnancy, especially when taken in the context of poverty and psychological distress, are important risk factors for adverse maternal and child outcomes. 4, 5 Systematic evaluation of CM parameters to determine optimal intervention models in special populations, such as in methadone-maintained opioid-dependent pregnant women, is needed. 1 The Drug Abuse Incentive Systems (DAISY) study, a randomized controlled trial (RCT), compared the relative efficacy of 13 weeks of escalating versus fixed CM voucher schedules for reducing opioid and cocaine use in methadone-maintained opioid-dependent pregnant women. Drug abstinence, defined as opioid (excluding methadone) and cocaine-negative urine toxicology laboratory test results, was the behavioral target for the DAISY study. A primary objective of the trial was to evaluate the efficacy of the CM schedules for initiating and sustaining abstinence from opioids and cocaine with the hypothesis that the escalating condition would prove superior to the fixed condition. 6 No significant difference in treatment efficacy by CM schedule was observed at 13 weeks, 6 but a review of CM has shown it to be efficacious in as little as 1 week. 3 In an effort to more fully examine CM's reinforcement parameters in this special population, this study aims to test the hypothesis that an escalating reinforcement schedule shows a superior outcome early on and is significantly more efficacious than a fixed schedule after only 5 weeks of intervention in opioid-dependent pregnant women. To test the hypothesis that there may have been an early effect that was not sustained throughout the 13-week study in this population of opioid-dependent pregnant women, a secondary data analysis was conducted to examine outcomes from the first 5 weeks of treatment. The primary aim of this study is to compare CM efficacy for the escalating and fixed schedules after 5 weeks of the intervention.
MATERIALS AND METHODS

Participants
Data were obtained from the DAISY parent study, a 13-week RCT of N = 133 opioid-dependent, agonist-maintained pregnant women (attendance control, n = 43; escalating CM, n = 52; fixed CM, n = 38). 6 All participants were undergoing treatment for substance use disorders at the Center for Addiction and Pregnancy in Baltimore, MD. 7, 8 Participation was voluntary and all participants signed an Institutional Review Boardapproved informed consent form. To complete the analysis comparing the efficacy of the CM schedules, only participants randomized to the escalating reinforcement condition and fixed reinforcement condition were included in this secondary data analysis (N = 90). Participants randomized to the attend-ance control condition in the parent study were excluded as this analysis did not include comparing the CM conditions to the control condition. The escalating and fixed reinforcement treatment conditions are described by Tuten et al. 6 
Outcome Measures
During the first 5 weeks of CM intervention, there were 14 opportunities for each participant to submit urine samples: 2 urine samples were submitted during the first week of the study and 1 sample 3 d/wk (every Monday, Wednesday, and Friday) for the following 4 weeks. To evaluate opioid and cocaine abstinence, 9 primary outcome measures were examined. Outcome measures were divided into 3 categories: (1) 
Analyses
Demographics and baseline characteristics were gathered for escalating and fixed CM participants. Continuous variables were analyzed using independent sample t tests and categorical variables were analyzed using the Fisher exact test. Continuous and categorical variables measuring opioid and cocaine abstinence at 5 weeks were analyzed using independent sample t tests and the Fisher exact test, respectively. The 5-week time frame was chosen, as opposed to 1 month, to more fully characterize the early response to the intervention, as the first full week of the intervention required participants to be in a more controlled inpatient setting. Missing urine samples from both CM conditions were imputed as positive for all analyses.
RESULTS
In the total sample, the mean age was 30 years and mean educational level was 11 years. Overall, 72% were African American, 73% were unmarried, and 96% were unemployed. Seventy-three percent of participants reported using cocaine and 94% heroin in the 30 days before enrollment. There were no significant differences in demographic and baseline characteristics found between escalating and fixed groups, except for race where there were significantly more black participants in the escalating condition (P = 0.05; Table 1 ). No statistically significant difference in any of the 9 measures of opioid and cocaine abstinence was found between escalating and fixed conditions after 5 weeks. At the end of 5 weeks, there were 14 opportunities for urine samples to be collected per participant and missing urine samples were imputed as positive. The mean (SD) number of drug-negative urines were 8.1 (4.5) and 7.4 (4.3), for escalating and fixed groups, respectively (P = 0.46; Table 2 ).
DISCUSSION
Although this study comparing escalating and fixed CM schedules found that the groups were similar on all measures of opioid and cocaine abstinence at the end of 5 weeks of intervention, Table 2 reports a pattern of results in favor of the escalating schedule. These results further the scientific knowledge regarding CM treatment parameters in opioid-dependent pregnant women by demonstrating that both the escalating and fixed CM schedule result in some abstinence from opioids and cocaine during early treatment.
The study was powered to detect effect sizes of Z0.61, and therefore would have detected any clinically significant effects. 9 Several factors may have contributed to the similar opioid and cocaine abstinence rates between CM schedules early in the intervention. The data for this analysis were collected as part of a trial in which the participants were earning vouchers based on their understanding of the trial and their earning potential lasting 13, not 5, weeks. As described by Tuten et al, 6 the absence of a reset mechanism for missed urine collections in the escalating condition as part of the design of the CM intervention may have contributed to the lack of 
Values are % or mean (SD). P values refer to comparisons between the escalating and fixed reinforcement conditions and are derived from an independent sample t test assuming unequal variances and Welch's approximation for calculation of degrees of freedom or from the Fisher exact test. superiority of the escalating schedule over the fixed schedule. These findings suggest that both escalating and fixed CM schedules, for durations of 5 and 13 weeks, have similar utility in assisting pregnant patients in achieving opioid and cocaine abstinence. Drug-negative was defined as a urine sample negative for opioids (excluding methadone) and cocaine; opioid-negative was defined as a urine sample negative for opioids excluding methadone. Values are mean (SD). P values refer to comparisons between the escalating and fixed reinforcement conditions and are derived from an independent sample t test assuming unequal variances and Welch's approximation for calculation of degrees of freedom.
